Glomerular pressure and tubular oxygen supply: a critical dual target for renal protection

Hypertens Res. 2024 Dec;47(12):3330-3337. doi: 10.1038/s41440-024-01944-9. Epub 2024 Oct 14.

Abstract

The primary treatment goal of chronic kidney disease (CKD) is preserving renal function and preventing its progression to end-stage renal disease. Glomerular hypertension and tubular hypoxia are critical risk factors in CKD progression. However, the renal hemodynamics make it difficult to avoid both factors due to the existence of peritubular capillaries that supply oxygen to the renal tubules downstream from the glomerulus through the efferent arteriole. In the treatment strategies for balancing glomerular pressure and tubular oxygen supply, afferent and efferent arterioles of the glomerulus determine glomerular filtration rate and blood flow to the peritubular capillaries. Therefore, sodium-glucose cotransporter 2 inhibitors and angiotensin receptor-neprilysin inhibitors as well as classical renin-angiotensin system inhibitors, which can change the diameter of afferent and/or efferent arterioles, are promising options for balancing this dual target and achieving renal protection. This review focuses on the clinical importance of glomerular pressure and tubular oxygen supply and proposes an effective treatment modality for this dual target.

Keywords: Angiotensin receptor–neprilysin inhibitor (ARNI); Glomerular hyperfiltration; Glomerular hypertension; Sodium-glucose cotransporter 2 (SGLT2) inhibitor; Tubular hypoxia.

Publication types

  • Review

MeSH terms

  • Animals
  • Glomerular Filtration Rate / drug effects
  • Humans
  • Kidney Glomerulus* / blood supply
  • Kidney Tubules* / metabolism
  • Oxygen / metabolism
  • Renal Insufficiency, Chronic / physiopathology
  • Sodium-Glucose Transporter 2 Inhibitors / pharmacology
  • Sodium-Glucose Transporter 2 Inhibitors / therapeutic use

Substances

  • Oxygen
  • Sodium-Glucose Transporter 2 Inhibitors